Skip to content

Pilot study on the use of neuromuscular stimulation (FlowAid) in patients with therapy-resistant venous leg ulcer

Pilot study on the use of neuromuscular stimulation (FlowAid) in patients with therapy-resistant venous leg ulcer - FlowAid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014744
Enrollment
20
Registered
2018-05-17
Start date
2018-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I87.21

Interventions

Group 1: The "FlowAid" device is used in the pilot study. By means of probes, which are glued to the skin at four points of the lower leg, the underlying calf muscles are to contract by electrical sti

Sponsors

St. Josef- und St. Elisabeth- Hospital gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: o Men and women o Age > 18 years o BMI up to 40 kg/m2 o Written consent o Patient in the vein centre o Primarily venous ulcer (recurrence or initial manifestation), diagnosis verified by DPPG and duplex sonography o Duration of the wound for at least 3 months o Stable wound progression with no healing tendency despite standard therapy in accordance with guidelines for at least 4 weeks (incl. phase-appropriate wound therapy and sufficient compression therapy) o Possibility and willingness to participate o Reduced mobility in the ankle/arthrogenic congestion syndrome

Exclusion criteria

Exclusion criteria: o acute TVT/ OVT (< 6 months) o lack of intellectual capacity to agree and answer questions o lack of motor skills or home help for the home use of FlowAid according to the protocol o Contraindications for the use of Flowaid o significant other cause of venous leg ulcer o short-term necessity of in-patient therapy o Pregnancy and lactation o ABI < 0.5 or absolute systolic ankle artery pressure < 60mmHg

Design outcomes

Primary

MeasureTime frame
The aim of the study is to observe the influence of FlowAid on the course of wound healing in venous leg ulcers. The most important criterion here is the wound size (max. length, max. width). This is documented in four rounds (at the beginning, one week later, five weeks after start and nine weeks after start). The treatment period is set at five weeks, a final assessment will be made four weeks later.

Secondary

MeasureTime frame
In addition to the primary criterion of wound size, the following factors are also assessed: o Exudation o Granulation o Pain o Quality of life o Infection o Course of healing o Handling Flowaid These are collected directly and with the help of questionnaires.

Countries

Germany

Contacts

Public ContactMaren Hoffmann

Venenzentrum St. Maria-Hilf Krankenhaus

maren.hoffmann@klinikum-bochum.de+49234-8792274

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026